2005/6:Sylvie Guerder - Toulouse Centre of Physiopathology, FranceAnalysis of the mechanisms of diabetes resistance in NOD mice deficient for a thymic serine endopeptidase: a model system to evaluate the potency of protease inhibition in preventing autoimmune disease. André Herchuelz - Brussels University, Belgium Prevention of beta-cell death in type 1 diabetes mellitus by modulation of intracellular Ca²+ homeostasis. Stephan Herzig - German Cancer Research Center Heidelberg, Germany Molecular control of hepatic energy metabolism through transcriptional co-factor TBL1. Marta Hribal - Catanzaro Magna Graecia University, Italy Role of the Akt specific phosphatase PHLPP in insulin action and in the pathogenesis of insulin resistance. Pierre Maechler - Geneva University, Switzerland Beta-cell specific abrogation of the gene encoding for glutamate dehydrogenase (GLUD1 ko)in transgenic mice and isolated islets. Michael Roden - Hanusch Hospital - Austria Mitochondrial dysfunction in human insulin resistance and diabetes: causes and consequences. Coen Stehouwer - Maastricht University - The Netherlands The role of ATF6, a key regulator of the unfolded protein response, in risk of type 2 diabetes. 2004/5:Per-Olof Berggren - Karolinska Institute, SwedenIncreased serum apoliprotein CIII and Ca2+ -dependent β-cell death. Per-Ola Carlsson - Uppsala University, Sweden Blood vessels in transplanted pancreatic islets. Miriam Cnop - Université Libre, Belgium Endoplasmic reticulum stress: a putative cause of nutrient- and obesity-induced pancreatic ß-cell dysfunction and death in type 2 diabetes. Lena Eliasson - Lund University, Sweden Regulation of insulin secretion by a specific miRNA and its target protein. Karlhans Endlich - Heidelberg University, Germany Diabetic nephropathy and mechanotransduction in podocytes. Martin R. Larsen - S. Denmark University, Denmark Do microparticles in plasma contain biomarkers for insulin-dependent type 1 diabetes (T1DM)? Stellan Sandler - Uppsala University, Sweden KATP-channel openers (KCO) as rescue drugs during acute β-cell destruction in type 1 diabetes. 2003/4:Peter Arner - Karolinska Institute, SwedenNovel adipocyte lipolysis mechanisms causing obesity mediated type 2 diabetes. Decio Eizirik - Université Libre Brussels, Belgium Mining genomic data to identify genes leading to β-cell death in type 1 diabetes mellitus. Heikki Hyöty - Tampere University, Finland Biobank of human diabetogenic enterovirus strains. Pierre Maechler - Geneva University, Switzerland Cloning and functional characterisation of the mitochondrial glutamate carrier 1 (GC1) in insulin secreting cells. Marcelina Párrizas - Institute for Biomedical Research Barcelona, Spain Role of transcription factor FOXO1 in β-cell function and differentiation. Michele Solimena - Dresden University, Germany Molecular machinery for the biogenesis of insulin secretory granules. Antonio Vidal-Puig - Addenbrooke's Hospital, United Kingdom Lipotoxicity and insulin resistance. characterisation of the SREBP1c skeletal muscle tissue specific knock-out mouse. |